Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control

Clinical trial NCT02913794 · COMPLETED

Trial details

NCT number: NCT02913794
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Study type: OBSERVATIONAL

Cardiovascular Diseases Hyperlipidemias

Start date: 2016-10-11
Primary completion: 2018-03-29
Enrollment: 541

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.